Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP503269.RAA9ZP4U64eXiT4e-jwtQiOpO1Dn1iJ0IePSkpfSPmxgI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP503269.RAA9ZP4U64eXiT4e-jwtQiOpO1Dn1iJ0IePSkpfSPmxgI130_assertion type Assertion NP503269.RAA9ZP4U64eXiT4e-jwtQiOpO1Dn1iJ0IePSkpfSPmxgI130_head.
- NP503269.RAA9ZP4U64eXiT4e-jwtQiOpO1Dn1iJ0IePSkpfSPmxgI130_assertion description "[The aim of this study was to investigate the occurrence and relevance of promoter methylation of the tumor suppressor DAPK-1, APAF-1 () and SPARC in relation to different pathological stages and histological grades of tumor progression that might act as possible independent prognostic factor in the susceptibility towards renal cell carcinoma (RCC) in North Indian population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503269.RAA9ZP4U64eXiT4e-jwtQiOpO1Dn1iJ0IePSkpfSPmxgI130_provenance.
- NP503269.RAA9ZP4U64eXiT4e-jwtQiOpO1Dn1iJ0IePSkpfSPmxgI130_assertion evidence source_evidence_literature NP503269.RAA9ZP4U64eXiT4e-jwtQiOpO1Dn1iJ0IePSkpfSPmxgI130_provenance.
- NP503269.RAA9ZP4U64eXiT4e-jwtQiOpO1Dn1iJ0IePSkpfSPmxgI130_assertion SIO_000772 21922274 NP503269.RAA9ZP4U64eXiT4e-jwtQiOpO1Dn1iJ0IePSkpfSPmxgI130_provenance.
- NP503269.RAA9ZP4U64eXiT4e-jwtQiOpO1Dn1iJ0IePSkpfSPmxgI130_assertion wasDerivedFrom befree-20140225 NP503269.RAA9ZP4U64eXiT4e-jwtQiOpO1Dn1iJ0IePSkpfSPmxgI130_provenance.
- NP503269.RAA9ZP4U64eXiT4e-jwtQiOpO1Dn1iJ0IePSkpfSPmxgI130_assertion wasGeneratedBy ECO_0000203 NP503269.RAA9ZP4U64eXiT4e-jwtQiOpO1Dn1iJ0IePSkpfSPmxgI130_provenance.